Every week, The American Journal of Managed Care\xae\xa0recaps the top managed care news of the week.\n\nThis week, the top managed care news included identification of insomnia as a risk factor for type 2 diabetes; a look at the growth of telehealth during coronavirus disease 2019; an overview of the speakers who will appear at Patient-Centered Oncology Care 2020.\n\nRead more about the stories in this podcast:\n\nStudy Finds Insomnia as New Risk Factor for Type 2 Diabetes: https://www.ajmc.com/view/study-finds-insomnia-as-new-risk-factor-for-type-2-diabetes\n\nThe Growth of Telehealth During COVID-19 and Its Future After: Dr Patricia Salber Interviews Dr Joseph Kvedar: https://www.ajmc.com/view/the-growth-of-telehealth-during-covid-19-and-its-future-after-dr-patricia-salber-interviews-dr\n\nPCOC 2020: Cancer Care Transformation Continues During COVID-19: https://www.ajmc.com/view/pcoc-2020-cancer-care-transformation-continues-during-covid-19\n\nEquity in Care Delivery Still at Top of PCOC 2020 Agenda, Amid \u201cUndue Burden\u201d: https://www.ajmc.com/view/equity-in-care-delivery-still-at-top-of-pcoc-2020-agenda-amid-undue-burden\n\nPCOC20 registration: https://event.ajmc.com/event/a8831e3f-8e98-4837-88fc-780d4f4eca61/regProcessStep1\n\nFDA Clears Targeted Therapy, Diagnostic for Metastatic RET Fusion-Positive NSCLC: https://www.ajmc.com/view/fda-clears-targeted-therapy-diagnostic-for-metastatic-ret-fusion-positive-nsclc\n\nThe Promise and Perils of Big Data in Healthcare: https://www.ajmc.com/view/the-promise-and-perils-of-big-data-in-healthcare